{"id":2758,"date":"2023-05-09T22:11:32","date_gmt":"2023-05-10T05:11:32","guid":{"rendered":"http:\/\/www.armenshirvanian.com\/podcast\/?p=2758"},"modified":"2023-05-09T22:11:36","modified_gmt":"2023-05-10T05:11:36","slug":"395-leroy-hood-nathan-price-personalized-predictive-health-in-the-age-of-scientific-wellness","status":"publish","type":"post","link":"https:\/\/www.armenshirvanian.com\/podcast\/395-leroy-hood-nathan-price-personalized-predictive-health-in-the-age-of-scientific-wellness\/","title":{"rendered":"395: Leroy Hood & Nathan Price | Personalized Predictive Health In “The Age of Scientific Wellness”"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

A world-renowned scientist and recipient of the National Medal of Science in 2011, Dr. Leroy Hood co-founded the Institute for Systems Biology (ISB) in 2000, served as its first President from 2000-2017 and is a Professor and Chief Strategy Officer. In 2016, ISB affiliated with Providence where Dr. Hood now serves as Emeritus Science Advisor.<\/p>\n\n\n\n

He received his MD from Johns Hopkins University School of Medicine and his PhD in biochemistry from Caltech. Dr. Hood was a faculty member at Caltech from 1967-1992, serving for 10 years as the Chair of Biology. During this period, he and his colleagues developed four sequencer and synthesizer instruments that paved the way for the Human Genome Project\u2019s successful mapping and understanding of the human genome. He and his students also deciphered many of the complex mechanisms of antibody diversification. In 1992, Dr. Hood founded and chaired the Department of Molecular Biotechnology at the University of Washington, the first academic department devoted to cross-disciplinary biology.<\/p>\n\n\n\n

Dr. Hood is currently carrying out studies in Alzheimer\u2019s Disease, cancer, and wellness. He is pioneering a 1 million patient genome\/phenome project, and is bringing scientific (quantitative) wellness to the contemporary U.S. health care system.<\/p>\n\n\n\n

Dr. Hood has played a role in founding 15 biotechnology companies including Amgen, Applied Biosystems, Arivale, and Nanostring. He has co-authored textbooks in biochemistry, immunology, molecular biology, genetics, and systems biology.<\/p>\n\n\n\n

Dr. Nathan Price is CEO of Onegevity, a division of Thorne HealthTech. He is also a (on leave) Professor at the Institute for Systems Biology, where he and Lee Hood co-direct the Hood-Price Lab for Systems Biomedicine. Additionally, Dr. Price is an affiliate faculty at the University of Washington in the Departments of Bioengineering, Computer Science & Engineering, and Molecular & Cellular Biology. In 2019, he was selected by the National Academy of Medicine as one of their 10 Emerging Leaders in Health and Medicine.<\/p>\n\n\n\n

Dr. Price co-founded Arivale, a scientific wellness company, that was named as\u202fGeekwire\u2019s 2016 startup of the year. Dr. Price is a member of the Board of Trustees of the Health and Environmental Sciences Institute (HESI) and is on the Board of Advisors for the American Cancer Society (WA).\u202fHe was also the chair of the NIH study section on Modeling and Analysis of Biological Systems (MABS).<\/p>\n\n\n\n

Dr. Price has also served on numerous scientific advisory boards, including for Roche (personalized healthcare division), Providence St. Joseph Health, Sera Prognostics, Trelys, Basepaws, the Personalized Lifestyle Medicine Thought Leaders Council, and the Novo Nordisk Foundation Center for Biosustainability.\u202fDr. Price served on the National Academy of Medicine committee to set best practice guidelines for developing omics-based\u202ftests in clinical trials from 2010-2012. He has served on the editorial boards of several scientific journals, including\u202fCell Systems<\/em>,\u202fScience Translational Medicine<\/em>,\u202fBMC Systems Biology<\/em>,\u00a0Industrial Biotechnology<\/em>,\u00a0Biotechnology Journal<\/em>,\u202fand was previously a Deputy Editor of\u202fPLOS Computational Biology<\/em>. He is also a fellow of the European Society of Preventive Medicine. He has published over 180 scientific papers (H-index > 62) and given over 200 invited talks.<\/p>\n\n\n\n

\n